Unknown

Dataset Information

0

Test-retest reproducibility of quantitative binding measures of [11C]Ro15-4513, a PET ligand for GABAA receptors containing alpha5 subunits.


ABSTRACT:

Introduction

Alteration of ?-aminobutyric acid "A" (GABAA) receptor-mediated neurotransmission has been associated with various neurological and psychiatric disorders. [11C]Ro15-4513 is a PET ligand with high affinity for ?5-subunit-containing GABAA receptors, which are highly expressed in limbic regions of the human brain (Sur et al., 1998). We quantified the test-retest reproducibility of measures of [11C]Ro15-4513 binding derived from six different quantification methods (12 variants).

Methods

Five healthy males (median age 40 years, range 38-49 years) had a 90-min PET scan on two occasions (median interval 12 days, range 11-30 days), after injection of a median dose of 441 MegaBequerels of [11C]Ro15-4513. Metabolite-corrected arterial plasma input functions (parent plasma input functions, ppIFs) were generated for all scans. We quantified regional binding using six methods (12 variants), some of which were region-based (applied to the average time-activity curve within a region) and others were voxel-based: 1) Models requiring arterial ppIFs - regional reversible compartmental models with one and two tissue compartments (2kbv and 4kbv); 2) Regional and voxelwise Logan's graphical analyses (Logan et al., 1990), which required arterial ppIFs; 3) Model-free regional and voxelwise (exponential) spectral analyses (SA; (Cunningham and Jones, 1993)), which also required arterial ppIFs; 4) methods not requiring arterial ppIFs - voxelwise standardised uptake values (Kenney et al., 1941), and regional and voxelwise simplified reference tissue models (SRTM/SRTM2) using brainstem or alternatively cerebellum as pseudo-reference regions (Lammertsma and Hume, 1996; Gunn et al., 1997). To compare the variants, we sampled the mean values of the outcome parameters within six bilateral, non-reference grey matter regions-of-interest. Reliability was quantified in terms of median absolute percentage test-retest differences (MA-TDs; preferentially low) and between-subject coefficient of variation (BS-CV, preferentially high), both compounded by the intraclass correlation coefficient (ICC). These measures were compared between variants, with particular interest in the hippocampus.

Results

Two of the six methods (5/12 variants) yielded reproducible data (i.e. MA-TD <10%): regional SRTMs and voxelwise SRTM2s, both using either the brainstem or the cerebellum; and voxelwise SA. However, the SRTMs using the brainstem yielded a lower median BS-CV (7% for regional, 7% voxelwise) than the other variants (8-11%), resulting in lower ICCs. The median ICCs across six regions were 0.89 (interquartile range 0.75-0.90) for voxelwise SA, 0.71 (0.64-0.84) for regional SRTM-cerebellum and 0.83 (0.70-0.86) for voxelwise SRTM-cerebellum. The ICCs for the hippocampus were 0.89 for voxelwise SA, 0.95 for regional SRTM-cerebellum and 0.93 for voxelwise SRTM-cerebellum.

Conclusion

Quantification of [11C]Ro15-4513 binding shows very good to excellent reproducibility with SRTM and with voxelwise SA which, however, requires an arterial ppIF. Quantification in the ?5 subunit-rich hippocampus is particularly reliable. The very low expression of the ?5 in the cerebellum (Fritschy and Mohler, 1995; Veronese et al., 2016) and the substantial ?1 subunit density in this region may hamper the application of reference tissue methods.

SUBMITTER: McGinnity CJ 

PROVIDER: S-EPMC5440177 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Test-retest reproducibility of quantitative binding measures of [<sup>11</sup>C]Ro15-4513, a PET ligand for GABA<sub>A</sub> receptors containing alpha5 subunits.

McGinnity Colm J CJ   Riaño Barros Daniela A DA   Rosso Lula L   Veronese Mattia M   Rizzo Gaia G   Bertoldo Alessandra A   Hinz Rainer R   Turkheimer Federico E FE   Koepp Matthias J MJ   Hammers Alexander A  

NeuroImage 20170311


<h4>Introduction</h4>Alteration of γ-aminobutyric acid "A" (GABA<sub>A</sub>) receptor-mediated neurotransmission has been associated with various neurological and psychiatric disorders. [<sup>11</sup>C]Ro15-4513 is a PET ligand with high affinity for α5-subunit-containing GABA<sub>A</sub> receptors, which are highly expressed in limbic regions of the human brain (Sur et al., 1998). We quantified the test-retest reproducibility of measures of [<sup>11</sup>C]Ro15-4513 binding derived from six di  ...[more]

Similar Datasets

| S-EPMC8138337 | biostudies-literature
| S-EPMC8206809 | biostudies-literature
| S-EPMC8786991 | biostudies-literature